Clinical Trial Update: Phase 2 Study of Neoadjuvant PEMbrolizumab Before Radical PROstatectomy in High-risk Prostate Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 study investigating neoadjuvant PEMbrolizumab before radical prostatectomy in high-risk prostate cancer patients is reported as an update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN